TW200731986A - Use of vaccines for the treatment/prevention of the transmission of pathogens - Google Patents
Use of vaccines for the treatment/prevention of the transmission of pathogensInfo
- Publication number
- TW200731986A TW200731986A TW095139655A TW95139655A TW200731986A TW 200731986 A TW200731986 A TW 200731986A TW 095139655 A TW095139655 A TW 095139655A TW 95139655 A TW95139655 A TW 95139655A TW 200731986 A TW200731986 A TW 200731986A
- Authority
- TW
- Taiwan
- Prior art keywords
- animal
- species
- prevention
- transmission
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73099805P | 2005-10-28 | 2005-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200731986A true TW200731986A (en) | 2007-09-01 |
Family
ID=38006396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095139655A TW200731986A (en) | 2005-10-28 | 2006-10-27 | Use of vaccines for the treatment/prevention of the transmission of pathogens |
Country Status (12)
Country | Link |
---|---|
US (1) | US8883123B2 (zh) |
EP (1) | EP1942924B1 (zh) |
JP (1) | JP2009513667A (zh) |
KR (1) | KR20080065680A (zh) |
CN (2) | CN101300023A (zh) |
AR (1) | AR056733A1 (zh) |
AT (1) | ATE543512T1 (zh) |
AU (1) | AU2006309007A1 (zh) |
BR (1) | BRPI0617952A2 (zh) |
CA (1) | CA2626866A1 (zh) |
TW (1) | TW200731986A (zh) |
WO (1) | WO2007053446A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0617952A2 (pt) | 2005-10-28 | 2011-08-09 | Boehringer Ingelheim Vetmed | composição antigênica compreendendo um antìgeno de um patógeno de um animal de uma primeira espécie, bem como uso de vacinas para o tratamento/prevenção da transmissão de patógenos da gripe entre espécies |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
US20090246226A1 (en) * | 2008-03-28 | 2009-10-01 | Zeon Corporation | Avian vaccines possessing a positive marker gene |
DE102008002641A1 (de) * | 2008-06-25 | 2009-12-31 | Biotronik Vi Patent Ag | Faserstrang und implantierbarer Stützkörper mit einem Faserstrang |
AU2009283557B2 (en) * | 2008-08-18 | 2013-01-17 | Kitasato Daiichi Sankyo Vaccine Co., Ltd. | Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration |
CN102281896A (zh) * | 2008-11-19 | 2011-12-14 | 阿维-梅克斯实验室公司 | 重组失活病毒载体疫苗 |
EP2367566B2 (en) | 2008-11-28 | 2019-11-27 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant avian influenza vaccine and uses thereof |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
WO2014127825A1 (en) * | 2013-02-21 | 2014-08-28 | Boehringer Ingelheim Vetmedica Gmbh | H5 proteins of h5n1 influenza virus for use as a medicament |
EP3039036B1 (en) | 2013-08-28 | 2019-05-22 | GlaxoSmithKline Biologicals S.A. | Novel influenza antigens and antibodies |
JP7337921B2 (ja) * | 2018-11-06 | 2023-09-04 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 鳥インフルエンザウイルスh5亜型に対する免疫原性組成物 |
MX2019014943A (es) * | 2018-12-12 | 2020-08-06 | Cambridge Tech Llc | Vacuna universal contra la gripe. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552758A (en) * | 1983-12-20 | 1985-11-12 | St. Jude Children's Research Hospital | Human use of avian-human reassortants as vaccines for influenza A virus |
US6204281B1 (en) * | 1998-07-10 | 2001-03-20 | Novartis Ag | Method of treatment and pharmaceutical composition |
JPWO2002062381A1 (ja) * | 2001-02-05 | 2004-06-03 | 久光製薬株式会社 | バキュロウイルスベクターワクチン |
US20040219208A1 (en) * | 2001-08-03 | 2004-11-04 | Ryu Kawamura | Sustained-release medicines |
WO2005018539A2 (en) * | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
DE202005022108U1 (de) * | 2004-03-09 | 2013-11-12 | Novartis Vaccines And Diagnostics, Inc. | Influenza-Virus-Impfstoffe |
CN1748795A (zh) | 2004-09-17 | 2006-03-22 | 金宁一 | 多价禽流感重组活载体疫苗 |
KR20060089393A (ko) * | 2005-02-04 | 2006-08-09 | 주식회사 중앙백신연구소 | 돼지 인플루엔자 바이러스a/swine/korea/s83/2004(h9n2) 및 이의백신 |
KR20080052509A (ko) | 2005-04-11 | 2008-06-11 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 | 유행성 독감 바이러스에 대한 백신 |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
BRPI0617952A2 (pt) | 2005-10-28 | 2011-08-09 | Boehringer Ingelheim Vetmed | composição antigênica compreendendo um antìgeno de um patógeno de um animal de uma primeira espécie, bem como uso de vacinas para o tratamento/prevenção da transmissão de patógenos da gripe entre espécies |
US8202967B2 (en) * | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
-
2006
- 2006-10-27 BR BRPI0617952-5A patent/BRPI0617952A2/pt not_active IP Right Cessation
- 2006-10-27 AT AT06836580T patent/ATE543512T1/de active
- 2006-10-27 CN CNA2006800400455A patent/CN101300023A/zh active Pending
- 2006-10-27 WO PCT/US2006/041989 patent/WO2007053446A2/en active Application Filing
- 2006-10-27 CA CA002626866A patent/CA2626866A1/en not_active Abandoned
- 2006-10-27 TW TW095139655A patent/TW200731986A/zh unknown
- 2006-10-27 AU AU2006309007A patent/AU2006309007A1/en not_active Abandoned
- 2006-10-27 KR KR1020087012894A patent/KR20080065680A/ko not_active Application Discontinuation
- 2006-10-27 CN CN2011103839490A patent/CN102406932A/zh active Pending
- 2006-10-27 AR ARP060104694A patent/AR056733A1/es not_active Withdrawn
- 2006-10-27 EP EP06836580A patent/EP1942924B1/en active Active
- 2006-10-27 US US11/553,492 patent/US8883123B2/en active Active
- 2006-10-27 JP JP2008537991A patent/JP2009513667A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US8883123B2 (en) | 2014-11-11 |
WO2007053446A3 (en) | 2007-08-16 |
BRPI0617952A2 (pt) | 2011-08-09 |
AU2006309007A1 (en) | 2007-05-10 |
AU2006309007A8 (en) | 2008-06-19 |
EP1942924B1 (en) | 2012-02-01 |
CN101300023A (zh) | 2008-11-05 |
US20070207168A1 (en) | 2007-09-06 |
KR20080065680A (ko) | 2008-07-14 |
EP1942924A2 (en) | 2008-07-16 |
JP2009513667A (ja) | 2009-04-02 |
CA2626866A1 (en) | 2007-05-10 |
ATE543512T1 (de) | 2012-02-15 |
CN102406932A (zh) | 2012-04-11 |
AR056733A1 (es) | 2007-10-17 |
WO2007053446A2 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200731986A (en) | Use of vaccines for the treatment/prevention of the transmission of pathogens | |
UA100507C2 (ru) | Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd) | |
TW200738270A (en) | Method of treating depression using a TNFα antibody | |
WO2007030810A3 (en) | Multiparameter whole blood monitor and method | |
WO2009118662A3 (en) | Methods and compositions for treating bone loss | |
TW200633719A (en) | Glycoconjugate vaccines containing peptidoglycan | |
MX2010006823A (es) | Metodos para el tratamiento de la gota. | |
MY153228A (en) | Composition to treat and/ or prevent gastrointestinal infection | |
MX2010009724A (es) | Procedimientos de tratamiento del dolor inflamatorio-. | |
TW200728466A (en) | Antibody molecules having specificity for human IL-6 | |
MX2007012702A (es) | Uso de anticuerpos cd25 en inmunoterapia. | |
WO2007056540A3 (en) | Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy | |
UA104129C2 (ru) | Уменьшение сопутствующих инфекций у свиней с помощью антигена pcv2 | |
PT2126049E (pt) | Anticorpos contra citomegalovírus humano (hcmv) | |
WO2008127296A3 (en) | Methods and compositions for treating tularemia | |
WO2009114560A3 (en) | Compositions and methods for the therapy and diagnosis of cytomegalovirus infections | |
EA201991126A1 (ru) | Снижение вирулентности бактерий путем снижения транспорта фолата у бактерий | |
EP1471936A4 (en) | HIV VACCINE AND METHOD OF USE | |
WO2008127279A3 (en) | Methods for treating, preventing and diagnosing porcine ttv infection | |
MX2009003301A (es) | Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas. | |
NO20070351L (no) | Materialer og fremgangsmater for forbedring av skalldyrhelse, -immunitet og -vekst | |
MY172788A (en) | Influenza vaccines | |
TW200531701A (en) | Method of vaccination against testicular BVDV infection | |
WO2005105135A8 (en) | Il-6 for therapy or prevention of chemotherapy-induced neuropathy | |
MX2009011312A (es) | Regimen de vacunacion para vacunas de celulas b. |